SNS-595 and methods of using the same

Details for Australian Patent Application No. 2005222607 (hide)

Owner Sunesis Pharmaceuticals, Inc.

Inventors Walker, Duncan; Arkin, Michelle; Wright, Jasmine; Hyde, Jennifer

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005222607

PCT Pub. Number WO2005/089756

Priority 60/553,578 15.03.04 US

Filing date 14 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 25 November 2010

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089756 Priority application(s): WO2005/089756

25 November 2010 Application Accepted

  Published as AU-B-2005222607

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222608-Intranasal benzodiazepine compositions

2005222604-Infectious Bursal Disease Virus antigenic isolates and vaccines